VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $183,000 | -57.2% | 12,669 | -50.6% | 0.01% | -58.3% |
| Q2 2017 | $428,000 | +205.7% | 25,633 | +74.9% | 0.01% | +200.0% |
| Q1 2017 | $140,000 | -22.2% | 14,655 | +24.6% | 0.00% | -33.3% |
| Q4 2016 | $180,000 | -20.7% | 11,765 | +23.2% | 0.01% | -33.3% |
| Q3 2016 | $227,000 | -3.0% | 9,552 | -6.2% | 0.01% | 0.0% |
| Q2 2016 | $234,000 | +15.3% | 10,188 | +410.9% | 0.01% | -10.0% |
| Q4 2015 | $203,000 | -46.3% | 1,994 | -5.9% | 0.01% | -52.4% |
| Q3 2015 | $378,000 | +58.2% | 2,118 | +27.0% | 0.02% | +40.0% |
| Q4 2014 | $239,000 | 0.0% | 1,668 | -8.6% | 0.02% | -11.8% |
| Q3 2014 | $239,000 | -48.9% | 1,824 | -48.6% | 0.02% | -65.3% |
| Q1 2014 | $468,000 | – | 3,549 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |